High national rates of high-dose dopamine agonist prescribing for restless legs syndrome

STUDY OBJECTIVES: Long-term dopamine agonist (DA) use in restless legs syndrome (RLS) is associated with augmentation, a dose-related symptom worsening leading to further dose escalation to manage RLS. This study investigated rates and factors of high-dose DA prescribing in US RLS patients. METHODS:...

Descripción completa

Detalles Bibliográficos
Autor principal: Winkelman, John W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Neurological Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842153/
https://www.ncbi.nlm.nih.gov/pubmed/34417810
http://dx.doi.org/10.1093/sleep/zsab212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842153/
https://www.ncbi.nlm.nih.gov/pubmed/34417810
http://dx.doi.org/10.1093/sleep/zsab212

Ejemplares similares